1-10 of 10
Lori Muffly
Close
Sort by
Articles

One on One With Fred Appelbaum

Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2024) 21 (4)
https://doi.org/10.1182/hem.V21.4.202447
Published: 2024
Articles

BMT-CTN 1506/MORPHO: A New Standard for MRD-directed Post-transplant Maintenance in Acute Myeloid Leukemia

Alexander Perl, MD, Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2024) 21 (3)
https://doi.org/10.1182/hem.V21.3.202439
Published: 2024
Articles

Toward Equity in Access for ALL

Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2024) 21 (1)
https://doi.org/10.1182/hem.V21.1.202417
Published: 2024
Articles

Two National Clinical Trials Poised to Expand the Role of Bone Marrow Transplant in Newly Diagnosed Severe Aplastic Anemia

Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2023) 20 (6)
https://doi.org/10.1182/hem.V20.6.202368
Published: 2023
Articles

Pre-MEASURE: Validation of NPM1/FLT3-ITD NGS-MRD as a Prognostic Tool in Transplantation for AML

Nikeshan Jeyakumar, MD, Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2023) 20 (4)
https://doi.org/10.1182/hem.V20.4.2023410
Published: 2023
Articles

Total Body Irradiation for Myeloablative Allogeneic Hematopoietic Transplantation in Acute Lymphoblastic Leukemia: How Important Is It Really?

Clayton Jackson, MD, Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2023) 20 (3)
https://doi.org/10.1182/hem.V20.3.202333
Published: 2023
Articles

ALLIANCE A042001: A Randomized Clinical Trial to Determine Whether Inotuzumab + Mini-HyperCVD Will Replace HyperCVAD As Frontline Treatment in Older Adult ALL

Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2023) 20 (2)
https://doi.org/10.1182/hem.V20.2.202326
Published: 2023
Articles

For Patients Facing Chronic GVHD, 2022 Was a Breakthrough Year

Arpita Gandhi, MD, MS, Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2023) 20 (1)
https://doi.org/10.1182/hem.V20.1.202316
Published: 2023
Articles

Should Minimal Residual Disease Guide the Way? The Evolving Role of Allogeneic Hematopoietic Cell Transplantation for Adults With Ph+ Acute Lymphoblastic Leukemia in First Complete Remission

Marc Schwartz, MD, Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2022) 19 (6)
https://doi.org/10.1182/hem.V19.6.202267
Published: 2022
Articles

Another Phase III Trial Confirms That the Standard of Care Is Difficult to Beat When It Comes to Allogeneic Hematopoietic Cell Transplantation

Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2022) 19 (5)
https://doi.org/10.1182/hem.V19.5.202252
Published: 2022